The Central Drugs Standard Control Organisation (CDSCO) is moving towards a smarter, risk-based regulatory approach that ...

Fermenta Biotech, India’s leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for the global markets, announced the signing of an Exclusive Licence Agreement with ...

The Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) launched BIO-NIVESH ...

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has ...

Sanofi will provide mentorship, market access support, and potential financial investment to Tricog, a health-tech startup ...

HRV Pharma announced it will invest Rs 150 crore to expand capabilities across two high-value and supply-constrained pharma segments, synthetic peptides and high-potency oncology APIs. The investment ...

The formulation integrates Ginsenoside phyto-exosomes, biomimetic peptides, copper peptides and stem cell-supportive actives to support follicular vitality, scalp health and the natural hair growth cy ...

She has held senior leadership roles at Eli Lilly, Elanco and Astellas Pharma, where she has focused on building and scaling ...

The growing use of non-surgical procedures in aesthetic dermatology is expanding the range of treatment options available for ...

Global pharma major Lupin announced that it has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets […] ...

Piyush Goyal, Union Minister of Commerce and Industry, Government of India, today inaugurated the Bharat Health Global Expo ...

Invagen Pharmaceuticals, a wholly owned subsidiary of Cipla announced that it has entered into a strategic partnership with Qilu Pharmaceutical, for the exclusive licensing and supply of QL2107, a ...